Synthesis and Evaluation of a Series of Bis(pentylpyridinium) Compounds as Antifungal Agents

ChemMedChem
Daniel ObandoKatrina A Jolliffe

Abstract

A series of bis(4-pentylpyridinium) compounds with a variety of spacers between the pyridinium headgroups was synthesised, and the antifungal activity of these compounds was investigated. Lengthening the alkyl spacer between the pentylpyridinium headgroups from 12 to 16 methylene units resulted in increased antifungal activity against C. neoformans and C. albicans, but also resulted in increased hemolytic activity and cytotoxicity against mammalian cells. However, inclusion of an ortho-substituted benzene ring in the centre of the alkyl spacer resulted in decreased cytotoxicity and hemolytic activity, while maintaining antifungal potency. Replacement of the alkyl and aromatic-containing spacers by more hydrophilic ethylene glycol groups resulted in a loss of antifungal activity. Some of the compounds inhibited fungal PLB1 activity, but the low correlation of this inhibition with antifungal potency indicates PLB1 inhibition is unlikely to be the predominant mode of antifungal action of this class of compounds, with preliminary studies suggesting they may act via disruption of fungal mitochondrial function.

References

Apr 1, 1989·Biochemical Society Transactions·G H De HaasR Verger
Oct 29, 1982·Biochemical and Biophysical Research Communications·H M KorchakG Weissmann
Feb 1, 1997·The Journal of Infectious Diseases·S C ChenT C Sorrell
Jul 4, 2001·Trends in Microbiology·R A Calderone, W A Fonzi
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Ranjini GanendrenLesley Wright
Sep 29, 2004·FEMS Microbiology Letters·Da-Kang ShenJean-François Brugère
Jan 20, 2006·Journal of Medicinal Chemistry·Clarissa K L NgKatrina A Jolliffe
Mar 27, 2007·Bioorganic & Medicinal Chemistry·Clarissa K L NgKatrina A Jolliffe
Oct 16, 2007·Clinical Microbiology Reviews·Marcio Nucci, Elias Anaissie
Aug 12, 2009·Bioorganic & Medicinal Chemistry·Daniel ObandoKatrina A Jolliffe
Dec 10, 2009·Molecular Aspects of Medicine·Feng WangPeng Huang
Jun 10, 2010·Antimicrobial Agents and Chemotherapy·Sharon C-A ChenTania C Sorrell
Apr 2, 2011·Molecular Microbiology·Methee ChayakulkeereeJulianne Teresa Djordjevic
May 26, 2011·Molecular Pharmacology·Xiaoming ZuoTania C Sorrell
Jun 10, 2011·Chemical Society Reviews·Rafael Chinchilla, Carmen Nájera
Jul 31, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jong H KimBruce C Campbell
May 24, 2015·FEMS Yeast Research·Richard CalderoneAna Traven
May 10, 2017·The Lancet Infectious Diseases·Radha RajasinghamDavid R Boulware
Aug 18, 2017·Infection and Drug Resistance·Elizabeth L Berkow, Shawn R Lockhart

❮ Previous
Next ❯

Citations

Jul 3, 2021·International Journal of Molecular Sciences·Anatoly N VereshchaginValentine P Ananikov
Nov 19, 2021··E. V. DetushevaA. N. Vereshchagin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.